Summary The Bacillus Calmette-Guérin vaccine has many off-target benefits, including
protection from diverse infectious diseases. As SARS-CoV-2 evolved, COVID-19 disease …

There is a need for safe and effective platform vaccines to protect against coronavirus
disease 2019 (COVID-19) and other infectious diseases. In this randomized, double …

Bacille Calmette–Guérin (BCG) vaccination, widely used throughout the world to protect
against infant tuberculous meningitis and miliary tuberculosis (TB), can provide broad non …

In late 2019, a new virulent coronavirus (CoV) emerged in Wuhan, China and was named as
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This virus spread rapidly …

The ongoing severe acute respiratory sickness coronavirus 2 (SARS‐CoV‐2) pandemic has
resulted in more than 3,600,000 detected cases of COVID‐19 illness and nearly 260,000 …

A series of epidemiological explorations has suggested a negative association between
national bacillus Calmette–Guérin (BCG) vaccination policy and the prevalence and …

The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
kept the whole world in tenterhooks due to its severe life‐threatening infectious disease …

The evidence that BCG (bacille Calmette-Guerin) vaccine may increase the ability of the
immune system to fight off pathogens other than tuberculosis has been studied in the past …

Summary Bacille Calmette-Guérin (BCG) induces long-term boosting of innate immunity,
termed trained immunity, and decreases susceptibility to respiratory tract infections. BCG …

BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
caused more than 1 million deaths worldwide; thus, there is an urgent need to develop …